Naomasa Yoshida

486 citations
33 papers · 398 indexed · h-index 7
Topics
Metastasis and carcinoma case studies (5 papers)Gastrointestinal Tumor Research and Treatment (4 papers)Renal cell carcinoma treatment (3 papers)
Partner nations
Japan

In The Last Decade

Naomasa Yoshida

23 papers receiving 363 citations

Peers

Naomasa Yoshida
Comparison fields: 5 of 71
  • Pharmacology 205
  • Molecular Biology 182
  • Plant Science 92
  • Oncology 57
  • Complementary and alternative medicine 47
Replace Zhipeng Du with:
Zhipeng Du China
Zi Ma China
M. V. Gazzola Italy
Weili Min China
Rongli You China
Liangpu Zheng China
Lingqin Song China
Hongsheng Lin China
Sheng‐Zhang Lin China
Naomasa Yoshida relative to Zhipeng Du China Zhipeng Du's profile →
Citations per field
00.5×4.6×
Zhipeng Du · 1×
Citations per year

Countries citing papers authored by Naomasa Yoshida

Since Specialization
Citations

This map shows the geographic impact of Naomasa Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomasa Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomasa Yoshida more than expected).

Fields of papers citing papers by Naomasa Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomasa Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomasa Yoshida. The network helps show where Naomasa Yoshida may publish in the future.

Co-authorship network of co-authors of Naomasa Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Naomasa Yoshida. A scholar is included among the top collaborators of Naomasa Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomasa Yoshida. Naomasa Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 6
4 3
5 10
6 13
7 5
8 1
9 7
10 7
11
Clinicopathological study of renal cell carcinoma.
5
12 4
13 3
14 1
15 0
16 6
17 4
18 261
19 1
20 5

About Naomasa Yoshida

Naomasa Yoshida is a scholar working on Hepatology, Gastroenterology and Applied Microbiology and Biotechnology, having authored 33 papers that have together received 398 indexed citations. Recurring topics across this work include Metastasis and carcinoma case studies (5 papers), Gastrointestinal Tumor Research and Treatment (4 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Pharmacology (205 citations), Complementary and alternative medicine (47 citations) and Pharmacology (31 citations). Naomasa Yoshida has collaborated with scholars based in Japan. Frequent co-authors include Kazunobu Sugimura, Shinichi Ikemoto, Seiji Wada, Taketoshi Kishimoto, Keisuke Yamamoto, Tatsuya Nakatani, Keisuke Narita, Yutaka Ozeki, Hirofumi Takemura and Hiroshi Matsuo. Their work appears in journals such as Journal of Thoracic and Cardiovascular Surgery, Urology and Journal of Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026